Posted in | News | Medical Optics

Iridian Spectral Technologies' Real-Time PCR Optical Filters

In an effort to support the rapidly growing use of polymerase chain reaction (PCR) in rapid diagnosis of diseases such as COVID-19, Iridian Spectral Technologies has introduced a line of ultra performance optical filters specifically designed for Real-Time PCR applications.  The ultra PCR fluorescence filter sets provide “more signal, with less background” improving the signal to noise ratio for these instruments.  

Standard filter sets address fluorochromes including:

  • FAM, HEX, ROX, Cy5, Cy5.5

These new filter offerings can be customized for specific instrument needs or to address other fluorescence channels and leverage Iridian’s more than two decades of experience producing high quality, high value optical filter solutions.  See more about Iridian’s solution for this application at:

https://www.iridian.ca/application-pcr-filters/

Thanks to all of our dedicated Iridian employees, especially those at work every day at our operation here in Ottawa, making possible our contribution to this ongoing fight against the COVID-19 pandemic.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Iridian Spectral Technologies. (2020, December 15). Iridian Spectral Technologies' Real-Time PCR Optical Filters. AZoOptics. Retrieved on June 12, 2021 from https://www.azooptics.com/News.aspx?newsID=26470.

  • MLA

    Iridian Spectral Technologies. "Iridian Spectral Technologies' Real-Time PCR Optical Filters". AZoOptics. 12 June 2021. <https://www.azooptics.com/News.aspx?newsID=26470>.

  • Chicago

    Iridian Spectral Technologies. "Iridian Spectral Technologies' Real-Time PCR Optical Filters". AZoOptics. https://www.azooptics.com/News.aspx?newsID=26470. (accessed June 12, 2021).

  • Harvard

    Iridian Spectral Technologies. 2020. Iridian Spectral Technologies' Real-Time PCR Optical Filters. AZoOptics, viewed 12 June 2021, https://www.azooptics.com/News.aspx?newsID=26470.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Submit